Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study
Open Access
- 15 March 2012
- Vol. 344 (mar15 3), e1533
- https://doi.org/10.1136/bmj.e1533
Abstract
Objective To assess the relation between troponin concentration, assay precision, and clinical outcomes in patients with suspected acute coronary syndrome. Design Cohort study. Setting Tertiary centre in Scotland. Participants 2092 consecutive patients admitted with suspected acute coronary syndrome were stratified with a sensitive troponin I assay into three groups (<0.012, 0.012-0.049, and ≥0.050 µg/L) based on the 99th centile for troponin concentration (0.012 µg/L; coefficient of variation 20.8%) and the diagnostic threshold (0.050 µg/L; 7.2%). Main outcome measure One year survival without events (recurrent myocardial infarction, death) in patients grouped by troponin concentration. Results Troponin I concentrations were <0.012 µg/L in 988 patients (47%), 0.012-0.049 µg/L in 352 patients (17%), and ≥0.050 µg/L in 752 patients (36%). Adoption of the 99th centile would increase the number of people receiving a diagnosis of myocardial infarction from 752 to 1104: a relative increase of 47%. At one year, patients with troponin concentrations of 0.012-0.049 µg/L were more likely to be dead or readmitted with recurrent myocardial infarction than those with troponin concentrations <0.012 µg/L (13% v 3%, P<0.001; odds ratio 4.7, 95% confidence interval 2.9 to 7.9). Compared with troponin ≥0.050 µg/L, patients with troponin 0.012-0.049 µg/L had a higher risk profile but were less likely to have a diagnosis of, or be investigated and treated for, acute coronary syndrome. Conclusion Lowering the diagnostic threshold to the 99th centile and accepting greater assay imprecision would identify more patients with acute coronary syndrome at risk of recurrent myocardial infarction and death but would increase the diagnosis of myocardial infarction by 47%. It remains to be established whether reclassification of these patients and treatment for myocardial infarction would improve outcome.Keywords
This publication has 25 references indexed in Scilit:
- Very early diagnosis of chest pain by point-of-care testing: comparison of the diagnostic efficiency of a panel of cardiac biomarkers compared with troponin measurement alone in the RATPAC trialHeart, 2011
- Rapid Exclusion of Acute Myocardial Infarction in Patients With Undetectable Troponin Using a High-Sensitivity AssayJournal of the American College of Cardiology, 2011
- The GRACE score's performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptideHeart, 2011
- Implementation of a Sensitive Troponin I Assay and Risk of Recurrent Myocardial Infarction and Death in Patients With Suspected Acute Coronary SyndromeJAMA, 2011
- Analytical characteristics of the Roche highly sensitive troponin T assay and its application to a cardio-healthy populationAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2010
- The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromesAmerican Heart Journal, 2010
- Being Rational about (Im)precision: A Statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the Definition of Myocardial InfarctionClinical Chemistry, 2010
- Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assayClinical Biochemistry, 2010
- Prospective Evaluation of the Prognostic Implications of Improved Assay Performance With a Sensitive Assay for Cardiac Troponin IJournal of the American College of Cardiology, 2010
- Sensitive Cardiac Troponin AssaysNew England Journal of Medicine, 2009